Marshall Wace
YTEN

Marshall Wace’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Marshall Wace’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,574
Closed -$474K – 3221
2021
Q1 		$474K Buy
+1,574
New +$532K ﹤0.01% 1967

Other funds holding YTEN

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace's YTEN Position: Q2 2021 in Review

Marshall Wace sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2021, closing a stake of 1,574 shares — an estimated $474K sold.

Marshall Wace first reported a position in YTEN in Q1 2021 and held it in 1 quarter. The position peaked at $474K in Q1 2021. 19 funds tracked by Wall St. Rank hold YTEN as of Q2 2021.

  • Marshall Wace reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace sold 1,574 Yield10 Bioscience, Inc. Common Stock shares in Q2 2021, an estimated $474K.
  • Marshall Wace first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Marshall Wace's Yield10 Bioscience, Inc. Common Stock position peaked at $474K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2021.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.